Boehringer Ingelheim plans for dealmaking and R&D spending amid US price pressure
Boehringer Ingelheim plans for dealmaking and R&D spending amid US price pressure
Boehringer Ingelheim plans for dealmaking and R&D spending amid US price pressure
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.